Clinical Trial Update: Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET [NA]

View source ↗

Summary

A terminated clinical trial from University of Lausanne Hospitals evaluating cardiac lesion angiogenesis using the 68Ga-NODAGA-RGD PET tracer in acute myocardia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Myocardial Infarction

Drugs mentioned

• 68Ga-NODAGA-RGD cardiac PET tracer (NODAGA-RGD)

Snippet

Sponsor: University of Lausanne Hospitals | Conditions: Myocardial Infarction, Acute, Myocardial Reperfusion | NA | Status: TERMINATED